Provexis plc (PXS.L) LSE

1.09

+0.06089994(+5.91%)

Updated at June 03 08:38AM

Currency In GBp

Provexis plc

Address

2 Blagrave Street

Reading, RG1 1AZ

United Kingdom of Great Britain and Northern Ireland (the)

Phone

44 7490 391 888

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

2

First IPO Date

June 28, 2004

Key Executives

NameTitlePayYear Born
Ian FordChief Executive Officer, Chief Financial Officer, Company Secretary & Executive Director185,6091965
Niamh Ann O'KennedyChief Scientific Officer, Member of Scientific Advisory Board & Executive Director39,7321973
Asim K. Duttaroy FICNConsultant & Member of Scientific Advisory Board0N/A

Description

Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and normal heart function. Provexis plc has a collaboration agreement with By-Health Co., Ltd. The company offers its products through retail stores, as well as online. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.